The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Emmens Matthew since 2011.
The trader's CIK number is 1298332.
At the time of the last reporting, Emmens Matthew was the CEO & President of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | VRTX | 0 | $0 | 66,850 | $2,535,903 | 0 | $0 |
| 2011 | VRTX | 0 | $0 | 9,735 | $540,389 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-11-16 | VRTX | Sale | 10,850 | 41.76 | 453,096 |
| 2011-02-06 | VRTX | Sale | 56,000 | 37.19 | 2,082,807 |
| 2011-05-25 | VRTX | Sale | 9,735 | 55.51 | 540,389 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Emmens Matthew (CEO & President of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.